Side-by-side comparison of AI visibility scores, market position, and capabilities
eVTOL pioneer (NYSE: ACHR). 100% FAA Means of Compliance acceptance. $1B+ United Airlines order. $2B liquidity. Targeting 2026 air taxi launch.
Archer Aviation is a Santa Clara-based electric vertical takeoff and landing (eVTOL) company founded in 2018 with the mission of advancing urban air mobility and making air taxis a reality for everyday commuters. The company designs, certifies, and plans to operate its own aircraft, taking a vertically integrated approach that gives it control over the full technology and customer stack. Its flagship aircraft, Midnight, is a piloted, four-passenger eVTOL designed to carry passengers on short urban routes with a targeted cost structure competitive with premium ground transportation.\n\nArcher's Midnight aircraft has achieved 100% FAA Means of Compliance acceptance — a critical regulatory milestone indicating that the FAA has approved the methods Archer will use to demonstrate airworthiness across the full vehicle. The company has secured a $1 billion-plus aircraft order from United Airlines, which intends to operate Archer flights as a premium airport shuttle service. Archer is listed on the NYSE under the ticker ACHR and maintains over $2 billion in liquidity, giving it a strong financial runway to complete certification and launch commercial service.\n\nArcher is targeting a 2026 commercial air taxi launch, with operations initially focused on high-demand airport corridor routes in major US metros. The company competes in the eVTOL sector alongside Joby Aviation and Lilium, but differentiates through its airline partnership with United, its regulatory progress, and its near-term commercial timeline. With FAA certification underway, a major airline as an anchor customer, and substantial capital on hand, Archer is among the best-positioned eVTOL companies to reach revenue-generating flight operations.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.